Impact of Decision-Framing in Psoriasis

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

October 21, 2019

Primary Completion Date

November 30, 2019

Study Completion Date

January 31, 2020

Conditions
Psoriasis VulgarisPsoriatic ArthritisPsoriasis
Interventions
BEHAVIORAL

Decision-Framed Survey

Survey will ask all subjects for will be asked to indicate basic demographic information, such as age, sex, race, and education level. Also, subjects will indicate whether they have been diagnosed with psoriatic arthritis. Importantly, patients will complete the survey questions anonymously, and no direct patient identifiers or HIPPA-protected information will be collected. Subjects will then be asked to indicate their preference for a hypothetical injectable medication after exposure to \[A\] a gain-framed message or \[B\] a loss-framed message.

Trial Locations (1)

90089

University of Southern California, Los Angeles

All Listed Sponsors
lead

University of Southern California

OTHER

NCT04136314 - Impact of Decision-Framing in Psoriasis | Biotech Hunter | Biotech Hunter